Coronavirus Pandemic


Class of 2022, First Year Fellows

    Emily Batton, MD

      Undergraduate | University of California, Los Angeles
      Post-graduate | Rush Medical College of Rush University Medical Center
      Residency | University of Chicago - Comer Children's Hospital

      Clinical and Research Interests | As a non-native Spanish speaking medical provider, Dr. Batton is interested in investigating how language differences between medical providers and parents of NICU patients affects parental satisfaction and newborn health outcomes. Literature has shown that Spanish speaking NICU parents with limited English proficiency are four times more likely to misunderstand their child’s diagnosis and feel less technically and emotionally prepared at NICU discharge compared to English speaking parents. However, little is known about their experience with communication in the NICU. Along with Dr. Krishelle Marc-Aurele, Dr. Batton plans to interview Spanish-speaking parents with a baby admitted to the neonatal intensive care unit about their experiences with communication in the NICU. Quantitative and qualitative analysis will be performed to examine challenges that prevent Spanish-speaking parents from learning about and participating in their child’s care. Guidance will be provided by Samantha Hurst, PhD, MA ,a medical anthropologist and Professor of qualitative methods and mixed methods research design for UCSD’s Public Health and Doctoral Programs. 

    Samantha Hietalati, MD
      Undergraduate | Hamline University
      Post-graduate | University of Minnesota Medical School
      Residency | Louisiana State University
      Clinical and Research Interests | TBD

    Meghana Karmarkar, MD

      Undergraduate | University of California, Los Angeles
      Post-graduate | Rush Medical College of Rush University Medical Center
      Residency | University of California, Los Angeles
      Clinical and Research Interests | Dr. Karmarkar focuses her research on quality
      improvement (QI) and patient safety. Currently, she is creating and implementing a clinical pathway to screen and manage NICU patients that are at risk for neonatal delirium. The NICU at Rady Children's Hospital has a unique population comprised of medically complex patients that have prolonged hospitalizations. These patients are often on multiple medications for pain and sedation, and require mechanical ventilation for extended periods of time - these factors, which if combined with an underlying acute illness, can lead to neonatal delirium. Although delirium is widely recognized in adult and pediatrics ICUs, it is not commonly diagnosed in the neonatal population. The goals of her QI project are to increase neonatal delirium screening rates for NICU patients and to decrease the overall use of benzodiazepine and opioid medications. Dr. Karmarkar is working with Dr. Laurel Moyer and Dr. Willough Jenkins on this project, who are providing their expertise in the areas of quality improvement and child psychiatry, respectively. Through this project, Dr. Karmarkar hopes to further her knowledge on QI methodology and how processes can be implemented in the healthcare system to improve patient outcomes.

Class of 2021, Second Year Fellows

    Shiyu (Sherry) Bai-Tong, MD

      Undergraduate | University of Southern California, Los Angeles
      Post-graduate | Case Western Reserve University School of Medicine
      Residency | Rainbow Babies and Children's Hospital

      Clinical and Research Interests |  Dr. Bai-Tong is interested the relationship between the preterm microbiome and feeding in the NICU as it impacts their risk of developing atopic disease later in life. Studies have shown term infants who later developed atopy can demonstrate transient gut dysbiosis during the first 3 months of life and that breastfeeding is protective. However, the impact of feeding type and the specific microbial pattern in allergy-prone preterm infants has not been studied. Her project Microbiome, Atopic Disease, and Prematurity (MAP Study) follows gut, oral and milk feed microbiome patterns in preterm infants during their NICU course and after discharge home, to discover patterns of the microbiome associated with the development of allergic sensitization patterns. She also studies the presence of non-human allergic peptides in milk feeds, as predictors for developing allergic sensitization in premature infants. 

She is co-mentored by Dr. Sandra Leibel from neonatology and Dr. Sydney Leibel from Allergy & Immunology while collaborating with multiple labs on UCSD campus including Dr. Rob Knight (microbiome), Dr. Jack Gilbert (microbiome), and Dr. Majid Ghassemian (proteomics).

   Rebecca Carter, MD

      Undergraduate | University of Georgia
      Post-graduate | Medical College of Georgia at Augusta University
      Residency | UCSF Benioff Children's Hospital Oakland
      Clinical and Research Interests | TBD

    Pamela Del Rosario, MD

      Undergraduate | University of California, Irvine
      Post-graduate | Ross University School of Medicine, Dominica
      Residency | Maimonides Medical Center
      Clinical and Research Interests | Basic Science Research: Prince Lab with Dr. Lance
      Prince and Graduate Researcher Sean Lund to investigate the molecular mechanisms that prevent the newborn lung immune system from detecting GBS. Results will identify new potential therapeutic strategies and approaches for treating newborn pneumonia.  QI Project: CPQCC Simulating Success project with Dr. Erika Fernandez to implement simulation-based neonatal resuscitation training programs in our NICU with the goal of improving resuscitation team performance during preterm and term deliveries.

Class of 2020, Third Year Fellows

    Brian Barnette, MD

      Undergraduate | University of Delaware
      Post-graduate | Temple University School of Medicine
      Residency | University of California, Davis
      Clinical and Research Interests | TBD

    Jenny Koo, MD

      Undergraduate University of California, Los Angeles
      Post-graduate | University of California, San Diego School of Medicine
      Residency | University of California, San Diego
      Clinical and Research Interests | Dr. Koo's research stems from her interest in neonatal
      sepsis. Neonates are born from a sterile, in utero environment to a world that is filled with pathogens. Moreover, the neonatal immune system is relatively immature, thus allowing neonates to be a heightened risk for severe infections. She is working with Dr. Shelley Lawrence and Dr. Victor Nizet to develop myeloid-cell coated nanoparticles, dubbed "nanosponges," as an adjuvant therapy for neonatal sepsis. While bacteriostatic and bacteriocidal antibiotics aid in the elimination of the pathogen, they do not alleviate the cytokine storm and overwhelming septic response in neonates that can result in end-organ damage and death. These "nanosponges" are designed to mimic the neonates cells and bind away bacterial toxins and inflammatory cytokines. This technology has already been shown to be effective against Group A Streptococcus, so her project will focus on targeting pathogens most commonly affiliated with neonatal sepsis, such as Group B Streptococcus, E. coli, etc. 

    Antonie Meixel, MD
      Undergraduate | University of California, Los Angeles
      Post-graduate | University of California, San Diego School of Medicine
      Residency | University of California, San Diego
      Clinical and Research Interests | TBD